Abstract
Optical immunosensing systems have become a commercial reality during the past three years, directed towards specific applications. All the technical challenges to allow quantitative immunosensors for decentralised testing have now been overcome and such devices should become a commercial reality during the 1990s.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
